BioCryst
Medical AFFAIRS
Navigate the Biocryst Medical Affairs Hub with ease
Throughout this resource hub you will find up-to-date information on developing and approved BioCryst medicines, including clinical trials, congress information, published data, and other research material.
Search for medical information
Find information on BioCryst products.
Find information
on upcoming and previous congresses
Upcoming Congress Events
European Academy of Allergy and Clinical Immunology (EAACI) Congress
BioCryst will attend the 2026 European Academy of Allergy and Clinical Immunology (EAACI) Congress from June 12 – June 15, 2026.
Visit the Congress Website for More Information
Materials From Recent Congresses
Showing 139 Materials
-
Clinical Outcomes With Navenibart According to Baseline Attack Rate, Body Mass Index, and Age: Results of the ALPHA-STAR Trial
EAACI | 2026 | HAE -
Hereditary Angioedema Attack Frequency and Severity According to Individuals Taking Berotralstat for Long-Term Prophylaxis
EAACI | 2026 | HAE -
Berotralstat Decreased HAE Attacks Treated with On-Demand Therapy or Utilising Professional Care in Paediatric Patients Aged 2 to <12 years: APeX-P Results Through 48 Weeks
EAACI | 2026 | HAE -
Reductions in Healthcare Resource Utilization in Adolescents with Hereditary Angioedema on Berotralstat
EAACI | 2026 | HAE -
Hereditary Angioedema Attack Rates among Patients with Normal C1 Esterase Inhibitor Before and After Switching from Another Long-Term Prophylaxis to Berotralstat
EAACI | 2026 | HAE
Current clinical trials and research
Learn more about medicines being developed at BioCryst and see the latest studies.
Discover more about our areas of focus
See our video library
Learn more about research within our areas of focus.
Ready to connect or have a question?
Have questions about any of our medicines that are approved or in development, or would you like to be connected with an MSL?
Have questions about our company?